|  |  | Baseline | Post-treatmenta | Mean change | MD (95% CI), Hedge’s g | Follow-upb | Mean change | MD (95% CI), Hedge’s g |
---|---|---|---|---|---|---|---|---|---|
DF (freq/wk) | Total | RA (n = 14) | 5.86 ± 5.62 | 5.43 ± 3.39 | −0.43 ± 4.09 | −1.70 (− 3.94, 0.55), | 5.79 ± 3.64 | − 0.07 ± 4.16 | −1.74 (− 4.13, 0.66), |
SA (n = 15) | 3.73 ± 1.62 | 5.00 ± 1.77 | 1.27 ± 1.10 | 0.56 | 5.40 ± 1.96 | 1.67 ± 1.72 | 0.53 | ||
Subgroup A | RA (n = 5) | 7.60 ± 9.40 | 6.60 ± 4.34 | −1.00 ± 5.66 | −1.75 (− 8.61, 5.11), | 7.80 ± 4.66 | 0.20 ± 5.76 | −0.30 (−7.34, 6.74), | |
SA (n = 4) | 4.00 ± 2.71 | 4.75 ± 2.36 | 0.75 ± 0.96 | 0.36 | 4.50 ± 1.73 | 0.50 ± 1.29 | 0.06 | ||
Subgroup B | RA (n = 9) | 7.00 ± 6.80 | 5.89 ± 3.86 | −1.11 ± 4.94 | −2.86 (−6.67, 0.94) | 6.67 ± 4.09 | −0.33 ± 5.12 | −2.58 (− 6.70, 1.54), | |
SA (n = 8) | 3.25 ± 0.71 | 5.00 ± 1.51 | 1.75 ± 1.04 | 0.74 | 5.50 ± 2.27 | 2.25 ± 1.98 | 0.62 | ||
SCBM (freq/wk) | Total | RA (n = 14) | 0.71 ± 1.20 | 3.21 ± 3.83 | 2.50 ± 3.86 | 0.17 (−2.37, 2.70), | 3.43 ± 4.05 | 2.71 ± 4.01 | 0.78 (−1.67, 3.24), |
SA (n = 15) | 1.13 ± 1.51 | 3.47 ± 2.45 | 2.33 ± 2.74 | 0.05 | 3.07 ± 2.19 | 1.93 ± 2.25 | 0.23 | ||
Subgroup A | RA (n = 5) | 0.60 ± 0.89 | 4.60 ± 5.18 | 4.00 ± 5.43 | 3.75 (−2.78, 10.28), | 6.00 ± 5.43 | 5.40 ± 5.37 | 4.90 (1.56, 11.36), | |
SA (n = 4) | 2.00 ± 2.71 | 2.25 ± 2.63 | 0.25 ± 0.50 | 0.81 | 2.50 ± 2.52 | 0.50 ± 0.58 | 1.07 | ||
Subgroup B | RA (n = 9) | 0.56 ± 0.88 | 3.22 ± 4.41 | 2.67 ± 4.33 | −0.21 (−3.88, 3.47), | 3.44 ± 4.90 | 2.89 ± 4.83 | 0.76 (−3.29, 4.82), | |
SA (n = 8) | 0.63 ± 0.52 | 3.50 ± 2.07 | 2.88 ± 2.36 | 0.06 | 2.75 ± 2.31 | 2.13 ± 2.47 | 0.18 | ||
BSS | Total | RA (n = 14) | 3.60 ± 1.09 | 4.17 ± 1.48 | 0.57 ± 1.72 | 0.42 (−0.66, 1.50), | 4.69 ± 0.82 | 1.09 ± 1.30 | 0.95 (0.11, 1.79), |
SA (n = 15) | 3.32 ± 1.38 | 3.47 ± 1.33 | 0.15 ± 1.06 | 0.29 | 3.46 ± 1.19 | 0.14 ± 0.88 | 0.84 | ||
Subgroup A | RA (n = 5) | 2.71 ± 0.64 | 4.68 ± 1.09 | 1.97 ± 1.23 | 1.06 (−0.64, 2.77), | 4.60 ± 0.23 | 1.89 ± 0.51 | 1.19 (0.34, 2.03), | |
SA (n = 4) | 1.46 ± 0.42 | 2.36 ± 1.08 | 0.91 ± 0.82 | 0.87 | 2.16 ± 0.90 | 0.70 ± 0.56 | 2.00 | ||
Subgroup B | RA (n = 9) | 3.31 ± 1.12 | 4.08 ± 1.80 | 0.78 ± 2.11 | 0.96 (−0.89, 2.82) | 5.01 ± 0.81 | 1.70 ± 1.10 | 1.91 (0.84, 2.98), | |
SA (n = 8) | 3.96 ± 1.31 | 3.77 ± 1.43 | −0.19 ± 1.35 | 0.51 | 3.75 ± 1.15 | −0.21 ± 0.95 | 1.76 | ||
CAS | Total | RA (n = 14) | 7.93 ± 4.01 | 4.71 ± 3.73 | −3.21 ± 2.91 | −0.55 (−2.73, 1.64), | 4.43 ± 3.98 | −3.50 ± 3.98 | −0.63 (−3.29, 2.02), |
SA (n = 15) | 7.27 ± 3.01 | 4.60 ± 2.41 | −2.67 + ±2.82 | 0.18 | 4.40 ± 2.85 | −2.87 ± 2.95 | 0.17 | ||
Subgroup A | RA (n = 5) | 10.40 ± 1.82 | 5.40 ± 1.82 | −5.00 ± 3.16 | −3.50 (−8.90, 1.90), | 4.20 ± 2.86 | −6.20 ± 4.15 | −4.70 (−11.10, 1.70), | |
SA (n = 4) | 6.25 ± 2.63 | 4.75 ± 1.50 | −1.50 ± 3.70 | 0.92 | 4.75 ± 1.71 | −1.50 ± 3.87 | 1.04 | ||
Subgroup B | RA (n = 9) | 10.56 ± 2.01 | 6.33 ± 3.67 | −4.22 ± 3.03 | −0.22 (−3.22, 2.77), | 5.56 ± 4.36 | −5.00 ± 3.84 | −1.00 (− 4.71, 2.71), | |
SA (n = 8) | 9.63 ± 1.85 | 5.63 ± 2.00 | −4.00 ± 2.73 | 0.08 | 5.63 ± 2.77 | −4.00 ± 3.25 | 0.27 |